Lv1
48 积分 2024-11-14 加入
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non–Small-Cell Lung Cancer (NSCLC)
23小时前
已完结
Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic Leukemia
6天前
已关闭
Effectiveness and safety of mogamulizumab for the treatment of Sézary syndrome in very elderly patients: A real‐world, multicentre, retrospective study conducted in France
7天前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
7天前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
7天前
已完结
Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel
14天前
已完结
Advances in Antibody–Drug Conjugates for Endometrial Cancer
16天前
已完结
HER2 testing: evolution and update for a companion diagnostic assay
20天前
已完结
HER2 immunoreactivity in advanced non-p53abn endometrial carcinoma: Association with clinical features, prognosis, and molecular characteristics
20天前
已关闭
HER2 expression in an endometrial cancer cohort
21天前
已完结
皖公网安备34019202002308
